MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13195-021-00787-7

Медицинская библиотека · Alzheimer's research & therapy · 2021

Cognitive trajectories of patients with focal ß-amyloid deposition.

Kim Si Eun, Lee Byungju, Jang Hyemin, Chin Juhee, Khoo Ching Soong, Choe Yeong Sim, Kim Ji Sun, Kang Sung Hoon, Kim Hang-Rai, Hwangbo Song, Jeong Jee Hyang, Yoon Soo Jin, Park Kyung Won, Kim Eun-Joo, Yoon Bora, Jang Jae-Won, Hong Jin Yong, Na Duk L, Seo Sang Won, Choi Seong Hye, Kim Hee Jin

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The presence of ß-amyloid (Aß) in the brain can be identified using amyloid PET. In clinical practice, the amyloid PET is interpreted based on dichotomous visual rating, which renders focal Aß accumulation be read as positive for Aß. However, the prognosis of patients with focal Aß deposition is not well established. Thus, we investigated cognitive trajectories of patients with focal Aß deposition.

METHODS

We followed up 240 participants (112 cognitively unimpaired [CU], 78 amnestic mild cognitive impairment [aMCI], and 50 Alzheimer's disease (AD) dementia [ADD]) for 2 years from 9 referral centers in South Korea. Participants were assessed with neuropsychological tests and 18F-flutemetamol (FMM) positron emission tomography (PET). Ten regions (frontal, precuneus/posterior cingulate (PPC), lateral temporal, parietal, and striatum of each hemisphere) were visually examined in the FMM scan, and participants were divided into three groups: No-FMM, Focal-FMM (FMM uptake in 1-9 regions), and Diffuse-FMM. We used mixed-effects model to investigate the speed of cognitive decline in the Focal-FMM group according to the cognitive level, extent, and location of Aß involvement, in comparison with the No- or Diffuse-FMM group.

RESULTS

Forty-five of 240 (18.8%) individuals were categorized as Focal-FMM. The rate of cognitive decline in the Focal-FMM group was faster than the No-FMM group (especially in the CU and aMCI stage) and slower than the Diffuse-FMM group (in particular in the CU stage). Within the Focal-FMM group, participants with FMM uptake to a larger extent (7-9 regions) showed faster cognitive decline compared to those with uptake to a smaller extent (1-3 or 4-6 regions). The Focal-FMM group was found to have faster cognitive decline in comparison with the No-FMM when there was uptake in the PPC, striatum, and frontal cortex.

CONCLUSIONS

When predicting cognitive decline of patients with focal Aß deposition, the patients' cognitive level, extent, and location of the focal involvement are important.

Для цитирования: Kim Si Eun, Lee Byungju, Jang Hyemin, Chin Juhee, Khoo Ching Soong, Choe Yeong Sim, Kim Ji Sun, Kang Sung Hoon, Kim Hang-Rai, Hwangbo Song, Jeong Jee Hyang, Yoon Soo Jin, Park Kyung Won, Kim Eun-Joo, Yoon Bora, Jang Jae-Won, Hong Jin Yong, Na Duk L, Seo Sang Won, Choi Seong Hye, Kim Hee Jin. Cognitive trajectories of patients with focal ß-amyloid deposition.. Alzheimer's research & therapy. 2021. DOI: 10.1186/s13195-021-00787-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.